首页> 美国卫生研究院文献>other >Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease Barrett’s esophagus and high-grade dysplasia/esophageal adenocarcinoma
【2h】

Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease Barrett’s esophagus and high-grade dysplasia/esophageal adenocarcinoma

机译:候选血清代谢物生物标志物用于区分胃食管反流病巴雷特食管和高度不典型增生/食管腺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction/ObjectivesIncidence of esophageal adenocarcinoma (EA), an often fatal cancer, has increased sharply over recent decades. Several important risk factors (reflux, obesity, smoking) have been identified for EA and its precursor, Barrett’s esophagus (BE), but a key challenge remains identifying individuals at highest risk, since most with reflux do not develop BE, and most with BE do not progress to cancer. Metabolomics represents an emerging approach for identifying novel biomarkers associated with cancer development.
机译:简介/目的食管腺癌(EA)是一种经常致命的癌症,近几十年来急剧上升。对于EA及其前体Barrett食道(BE),已经确定了几个重要的危险因素(反流,肥胖,吸烟),但是识别高危人群仍然是一项关键挑战,因为大多数患有反流的人不会发展BE,而大多数患有BE。不发展为癌症。代谢组学是一种鉴定与癌症发展相关的新型生物标志物的新兴方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号